Company: JUNS
Filing Date: 2025-11-06
Form Type: DEF 14A
Source: 0001493152-25-020988
Chunk: 80

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-11-06
Form: DEF 14A
Chunk 80
---
’s stockholders to be held on December 19, 2025 (the
“Annual Meeting”), among other things, the Company will seek the requisite stockholder approval in accordance with
Rule 5635(d) of the Nasdaq Listing Rules (in addition to the requisite stockholder approval under Nasdaq Listing Rule 5635(b)) to issue
and sell shares of Common Stock in excess of the 6,638,088 share Exchange Cap referred to above to Yorkville under the SEPA and
upon conversion of the Convertible Notes. Accordingly, if such requisite stockholder approval is obtained at the Annual Meeting, the
Company would be able to issue and sell to Yorkville in Advances under the SEPA as many shares of Common Stock as will be necessary for
the Company to obtain the entire $20.0 million aggregate purchase commitment made by Yorkville under the SEPA, which includes amounts
that are used as Advance Repayments of outstanding amounts under the Convertible Notes, and as many shares of Common Stock as will be
necessary to enable Yorkville to convert all outstanding amounts under the Convertible Notes that Yorkville elects to convert into shares
of Common Stock under the terms of the Convertible Notes, in each case, without any further aggregate share issuance limitations under
Nasdaq rules. However, the 6,638,088 share Exchange Cap will continue to limit issuances and sales of Common Stock by the Company
to Yorkville under the SEPA and upon conversion of the Convertible Notes, unless and until the Company has obtained such requisite stockholder
approval to issue shares of Common Stock in excess of the Exchange Cap to Yorkville under the SEPA and upon conversion of the Convertible
Notes in accordance with applicable Nasdaq rules.

| -44- |

In addition to the Exchange Cap discussed
above, the Company may not issue or sell any shares of Common Stock to Yorkville under the SEPA or upon conversion of the Convertible
Notes, which, when aggregated with all other shares of Common Stock then beneficially owned by Yorkville and its affiliates (as calculated
pursuant to Section 13(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the rules thereunder),
would result in Yorkville beneficially owning more than 4.99% (which Yorkville may increase to a higher percentage as specified in a
written notice thereof delivered to a Company, which will not be effective until the 65 day after delivery of